NCT06097221 The Advance Project - Advancing Sleep Timing to Improve Depression
| NCT ID | NCT06097221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Bispebjerg and Frederiksberg |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-04-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
150 patients with moderate to severe depression, recently discharged from a psychiatric ward and now recieving treatment at an outpatient unit at Mental Health Center Copenhagen, will be randomised in to two groups. A treatment ad usual (TAU) group and an Advance-group. The Advance-group will receive a psychotherapeutic intervention focusing on advancing sleep timing to improve depression.
Eligibility Criteria
Inclusion Criteria: * Moderate to major depression (DSM-V) * Discharge from psychiatric ward within last 30 days * Sleep onset and/or sleep off-set delayed minimum 1 hour based on the last three days, comparred to sleep in the last week of admittance at the psychiatric ward. Exclusion Criteria: * Psychotic depression. * Cognitive problems making participation difficult. * Substance abuse (e.g. alcohol). * Increased suicidal risk.
Contact & Investigator
Klaus Martiny, Professor
STUDY DIRECTOR
Mental Health Center Copenhagen
Frequently Asked Questions
Who can join the NCT06097221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06097221 currently recruiting?
Yes, NCT06097221 is actively recruiting participants. Contact the research team at anne.sofie.kvist.houby@regionh.dk for enrollment information.
Where is the NCT06097221 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06097221 clinical trial?
NCT06097221 is sponsored by University Hospital Bispebjerg and Frederiksberg. The principal investigator is Klaus Martiny, Professor at Mental Health Center Copenhagen. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.